AD-208

· Addpharma Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AD-208, covering 2023-07-21 to 2023-07-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of AD-208 [Phase 3]